Immunotech Biopharm Ltd (6978.HK)

HKD 2.47

(8.33%)

Long Term Debt Summary of Immunotech Biopharm Ltd

Immunotech Biopharm Ltd's latest annual long term debt in 2023 was 432.49 Million CNY , up 249.49% from previous year.
Immunotech Biopharm Ltd's latest quarterly long term debt in 2024 Q1 was - CNY , down -100.0% from previous quarter.
Immunotech Biopharm Ltd reported annual long term debt of 123.75 Million CNY in 2022, up 36.22% from previous year.
Immunotech Biopharm Ltd reported annual long term debt of 90.84 Million CNY in 2021, up 107.14% from previous year.
Immunotech Biopharm Ltd reported quarterly long term debt of - CNY for 2024 Q1, down -100.0% from previous quarter.
Immunotech Biopharm Ltd reported quarterly long term debt of 435.98 Million CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Immunotech Biopharm Ltd (2023 - 2018)

Historical Annual Long Term Debt of Immunotech Biopharm Ltd (2023 - 2018)

Year	Long Term Debt	Long Term Debt Growth
2023	432.49 Million CNY	249.49%
2022	123.75 Million CNY	36.22%
2021	90.84 Million CNY	107.14%
2020	43.85 Million CNY	24.54%
2019	35.21 Million CNY	13.75%
2018	30.95 Million CNY	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	- CNY	0.0%
2024 Q1	- CNY	-100.0%
2023 Q2	435.98 Million CNY	0.0%
2023 FY	432.49 Million CNY	249.49%
2023 Q1	435.98 Million CNY	252.31%
2023 Q4	432.49 Million CNY	0.0%
2023 Q3	432.49 Million CNY	-0.8%
2022 Q4	123.75 Million CNY	0.0%
2022 Q3	123.75 Million CNY	55.5%
2022 Q2	79.58 Million CNY	0.0%
2022 Q1	79.58 Million CNY	-12.4%
2022 FY	123.75 Million CNY	36.22%
2021 Q1	43.67 Million CNY	-0.42%
2021 Q2	43.67 Million CNY	0.0%
2021 FY	90.84 Million CNY	107.14%
2021 Q4	90.84 Million CNY	0.0%
2021 Q3	90.84 Million CNY	108.01%
2020 Q4	43.85 Million CNY	0.0%
2020 FY	43.85 Million CNY	24.54%
2020 Q3	43.85 Million CNY	31.68%
2020 Q2	33.3 Million CNY	0.0%
2020 Q1	33.3 Million CNY	-5.42%
2019 Q3	35.21 Million CNY	0.0%
2019 Q1	- CNY	0.0%
2019 Q4	35.21 Million CNY	0.0%
2019 FY	35.21 Million CNY	13.75%
2018 FY	30.95 Million CNY	0.0%

Peer Long Term Debt Comparison of Immunotech Biopharm Ltd

Name	Long Term Debt	Long Term Debt Difference
Uni-Bio Science Group Limited	30.61 Million HKD	-1312.825%
CK Life Sciences Int'l., (Holdings) Inc.	4.27 Billion HKD	89.878%